With the high recurrence rate of corticosteroid therapy, the discovery of the BAFF’s role in nephrotic syndrome will disclose new therapeutic opportunities that are effective in reducing the recurrence rate in nephrotic syndrome patients. This evidence concerns the gene TNFSF13B and nephrotic syndrome.